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Abstract
Background: Airway viral infections cause the exacerbations of asthma and chronic obstructive pulmonary disease.
PD-L1, also known as B7-H1, is an immune-checkpoint molecule that plays a role in an escape mechanism of
viruses from the host immune systems. This escape may be associated with the persistence of viral infection and
the exacerbation of the underlying diseases. In a study in vitro, we have shown that corticosteroids plus long-acting
beta2-agonists (LABAs) attenuate the upregulation of PD-L1 on airway epithelial cells stimulated with an analog of
viral double-stranded RNA, polyinosinic-polycytidylic acid (poly I:C). To address its biological relevance in vivo, we
investigated the effect of corticosteroid plus LABA on the expression of PD-L1 in double-stranded RNA-induced
lung inflammation in mice.
Methods: Mice were intratracheally administered with poly I:C. The expression of PD-L1 on the lung cells was
assessed by flow cytometry and inflammation was assessed for bronchoalveolar lavage fluid (BALF). Independent as
well as combination effects of ciclesonide and indacaterol were examined.
Results: Administration of low dose poly I:C upregulated the expression of PD-L1, induced neutrophilia and
increased keratinocyte-derived chemokine (KC), macrophage inflammatory protein-1β (MIP-1β), and IL-6 in BALF.
The upregulation of PD-L1, neutrophilic inflammation and increase of KC were suppressed by ciclesonide plus
indacaterol, but not by either when administered independently. Although the upregulation of PD-L1 by high dose
poly I:C was suppressed by ciclesonide plus indacaterol, neutrophilia and increased KC, MIP-1β, and IL-6 in BALF
were not attenuated.
Conclusions: Ciclesonide plus indacaterol attenuate double-stranded RNA-induced upregulation of PD-L1 in the
lungs.
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Background
Viral airway infections, such as rhinovirus, respiratory
syncytial virus (RSV), human metapeumovirus, and in-
fluenza virus, frequently cause the exacerbation of in-
flammatory airway diseases including asthma and
chronic obstructive pulmonary disease (COPD) [1–3].
These viruses possess single-stranded (ss) RNA as their
own genome. Influenza virus has a unique tri-
phosphate-ended double-stranded (ds) RNA-like struc-
ture at the 5’terminal of genomic ssRNA. Rhinovirus,
RSV, and human metapeumovirus generate dsRNA in
their host cells. These dsRNAs activate innate immune
responses through their binding to Toll-like receptor 3
(TLR3) and the family of RNA helicase, namely, the ret-
inoic acid-inducible gene I (RIG-I) and the melanoma
differentiation-associated gene 5 (Mda5) [4–6]. TLR3
recognizes viral dsRNA and a synthetic analog of
dsRNA, polyinocinic polycytidilic acid (poly I:C), in the
endosome, while RIG-I and Mda5 recognize dsRNA in
the cytoplasm. RIG-I recognizes dsRNA of RSV, human
metapeumovirus and influenza virus. Mda5 recognizes
dsRNA of rhinovirus and poly I:C. Subsequent signaling
leads to adapted antiviral immunity.
Adapted immune responses are initiated by the inter-
actions between antigen-presenting cells and T cells.
These interactions are characterized by the binding of a
variety of costimulatory and coinhibitory molecules, in-
cluding B7-family molecules, and their putative recep-
tors [7]. PD-L1, also named as B7-H1, belongs to the B7
family and shares its receptor, programmed death-1
(PD-1), with PD-L2, also named as B7-DC. PD-1 is in-
duced in T cells and B cells during their activation, and
its ligation to PD-L1 results in the inhibition of the acti-
vated status. PD-L1, PD-L2 and PD-1 have been known
as immune-checkpoint molecules in tumor and infection
immunity [8]. Previous studies showed that the blockade
of the PD-L1/PD-1 pathway restored the function of
virus-specific cytotoxic T lymphocytes (CTLs) and de-
creased the viral load, suggesting that PD-L1 upregula-
tion causes CTL exhaustion and then impairs virus
eradication [9–11]. The airway epithelial cells are tar-
geted by viruses for their replication. Human epithelial
cells constitutively expressed a low level of PD-L1 and
poly I:C stimulation upregulated the expression of PD-
L1 [12–14]. Given a high expression of PD-1 on virus-
specific CTLs, dsRNA-induced upregulation of PD-L1
may prevent the infected cells from attack by CTLs,
thereby facilitating the spread of a virus around the
neighboring cells [15]. Antigen-presenting cells, particu-
larly dendritic cells, are other important cells in the anti-
viral immune defense. Virus- or dsRNA-stimulated
dendritic cells trigger an array of anti-viral innate- and
adapted-immune responses [16]. On the other hand,
virus and dsRNA upregulates the expression of PD-L1
on dendritic cells, which may compromise the anti-viral
immune responses [17, 18].
Inhaled corticosteroids (ICSs) and long-acting beta2-
agonists (LABAs) are used worldwide for the treat-
ment of asthma and COPD. Clinical trials showed
that the combination of ICSs with LABAs improves
symptoms and lung function and reduces exacerba-
tions in subjects with asthma and COPD [19–21].
The mechanism of action for reducing exacerbation
has not fully been elucidated. We previously showed
that ICSs plus LABAs attenuate the poly IC- or RSV-
induced upregulation of PD-L1 on airway epithelial
cells in vitro [22]. To address its biological relevance
in vivo, we investigated the effect of corticosteroid
plus long-acting beta2-agonist on the expression of




Ciclesonide (CIC) was purchased from Santa Cruz Bio-
technology (Santa Cruz, CA, USA). Indacaterol maleate
(IND) was provided from Novartis Pharma AG (Basel,
Switzerland). Poly I:C and dimethyl sulfoxide (DMSO)
were purchased from SIGMA-ALDRICH (St. Louis, MO,
USA). Anti-mouse CD16/CD32 mAb was purchased from
BD Biosciences (San Diego, CA, USA). FITC-conjugated
mouse anti-keratin 5/8 monoclonal Ab (mAb) was pur-
chased from Progen (Heidelberg, Germany). Biotinylated
anti-human PD-L1 mAb and anti-mouse PD-L1 mAb
were purchased from eBioscience (San Diego, CA, USA).
Streptavidin-phycoerythrin (SAv-PE) conjugate was pur-
chased from BD Biosciences (San Jose, CA, USA).
Culture of airway epithelial cells
The BEAS-2B cell line, derived from human bronchial
epithelium transformed by an adenovirus 12-SV-40
virus, was cultured in 6-well plates by using DMEM/F12
containing 10% FBS, penicillin (100 U/ml), and strepto-
mycin (100 ng/ml) at 37 °C with 5% CO2 in humidified
air.
Stimulation of cells with dsRNA
When cells reached semi-confluence, they were stimu-
lated by administration of 3 μg/ml poly I:C in the culture
medium. After 4 h incubation, they were replaced with a
fresh medium. The cells were pretreated with CIC, IND,
CIC plus IND or vehicle alone for 2 h before the stimu-
lation. The cells were harvested 24 h after the
stimulation.
Mice
Male C57BL/6 mice (5–7 weeks old) were purchased
from SLC Japan and were housed under specific
Hamano et al. Journal of Inflammation  (2017) 14:2 Page 2 of 8
pathogen-free conditions until the experiments
commenced.
Protocols
Mice were anesthetized with 80 μg/kg dexmetdetomi-
dine i.p., subsequently with inhalation of 3–4% isoflur-
ane. A tracheal cannulation was temporally performed
with 20 gauge catheter. To elucidate time courses of
PD-L1 expression and airway inflammation induced by
poly I:C stimulation, mice were anesthetized and re-
ceived intratracheal instillation (i.t.) of poly I:C (30 μg, in
total volume of 50 μl). At 24, 72, and 168 h after poly
I:C stimulation, mice were sacrificed, bronchoalveolar
lavage was performed, and then the lungs were collected.
Mice received i.t. of poly I:C (3 or 30 μg, in total volume
of 50 μl), 4 h after the administration of CIC (3 μg, in
total volume of 50 μl) and/or IND (3 μg, in total volume
of 50 μl) i.t.. Poly I:C was dissolved in physiological sa-
line before use. CIC and IND were dissolved in DMSO
and diluted saline to 6% in final formulation. CIC and
IND were used immediately after preparation. Sham-
treated mice were used as controls. We provided ethics
approval information with protocol ID (A23-048-0 and
A25-007-0).
Bronchoalveolar lavage and ELISA
After 24 h of poly I:C administration, mice were sacri-
ficed under a mixture of ketamine and sodium pentobar-
bital i.p. injection, and their tracheas were cannulated
via tracheostomy. The lungs were lavaged with 1 ml of
PBS via tracheal cannula. Differential cell counts were
performed. Samples were centrifuged at 2000 rpm for
10 min, the supernatants were collected and the concen-
tration of keratinocyte-derived chemokine (KC), macro-
phage inflammatory protein-1β (MIP-1β) and IL-6 in
bronchoalveolar lavage fluid (BALF) were measured
using ELISA kit (BioSource, or R&D Systems).
Flow cytometric analysis
For BEAS-2B cell study, 5 × 106 cells were incubated in
100 μl of phosphate-buffered saline (PBS) with 0.5% BSA
and 0.02% NaN3 containing biotynilated anti-human
PD-L1 mAb at room temperature for 30 min. The sam-
ples were thoroughly washed and suspended in SAv-PE
conjugate for 20 min. After washing with PBS/0.5%
BSA/0.02% NaN3, the cells were fixed with 4% parafor-
maldehyde for 20 min. For in vivo study, lungs were cut
and minced. PBS containing 2 mM dithiothreitol, 5 mM
EDTA was added to the minced lungs and incubated for
40 min at 37 °C. The samples were filtered through a
70 μm pores size nylon cell strainer. The single-cell sus-
pensions were washed with complete PBS, and the
erythrocytes were lysed with an NH4Cl-Tris buffer. Cells
were suspended in PBS with 0.5% BSA and 0.02% NaN3,
and 0.02%EDTA, referred as a washing buffer. Cells were
preincubated with anti-mouse CD16/CD32 mAb to pre-
vent nonspecific binding via FcγR. For the dual-color
flow cytometry, cells were incubated with FITC-
conjugated anti-keratin 5/8 mAb for 30 min, followed by
the addition of biotinylated anti-mouse PD-L1 mAb for
30 min. The samples were washed with the washing buf-
fer and suspended in SAv-PE conjugate for 20 min. Cells
were thoroughly washed, fixed with 4% paraformalde-
hyde, and flow cytometric analysis was performed using
a FACSCalibur with CellQuest software (BD Biosciences,
CA, USA). Thirty thousand events were acquired in a
list mode with debris excluded by the forward-scatter
threshold. The mean fluorescence intensity (MFI) was
compared with control staining using an irrelevant
isotype-matched mAb.
Data analysis
Values were expressed as the means ± SEM. Differences
among groups were analyzed using an ANOVA followed
by the multiple comparison test of Tukey-Kramer. JMP
Pro 11 software was used for statistical analysis. P-values
less than 0.05 were accepted as statistically significant.
Results
The administration of poly I:C to the cell culture
medium significantly upregulated the expression of PD-
L1 on BEAS-2B cells. The upregulation of PD-L1 was
suppressed by CIC alone in a concentration-dependent
manner, and the upregulation of PD-L1 was significantly
suppressed by CIC at 1 nM (Fig. 1a). On the other hand,
IND alone had no effect on the upregulation of PD-L1
(Fig. 1b). Although CIC at 0.01 nM had no effect, CIC at
0.01 nM in combination with IND at 1 nM significantly
suppressed the upregulation of PD-L1 (Fig. 1c).
For in vivo experiments, administrations of poly I:C, 3
and 30 μg, were used as preclinical models of light and
heavy infections, respectively. It is known that anti-
keratin 5/8 mAb has been used for detecting epithelial
cell lineages in various organs including airway epithe-
lium [23–25]. In a preliminary study, we found that this
mAb also reacts with a part of CD45-positive myeloid-
derived cell lineages. Single saline (i.t.) administration
had no effect on the expression of PD-L1 in keratin 5/8
mAb-positive cells in flow cytometry. The administra-
tion of poly I:C, 30 μg, significantly upregulated the ex-
pression of PD-L1 compared to the sham-treated
control (Fig. 2a). The upregulation of PD-L1 was appar-
ent at 24 to 72 h after poly I:C administration. Poly I:C-
induced inflammation was assessed by differential cell
counts in BALF. The administration of poly I:C, 30 μg,
induced neutrophilia in BALF compared to the sham-
treated control (Fig. 2b). The neutrophilia was shown
24 h after poly I:C administration but rapidly disappear
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thereafter. In order to evaluate drug effects on the ex-
pression of PD-L1 and neutrophilic inflammation simul-
taneously, the time point at 24 h after poly I: C was
chosen for subsequent experiments.
Fluticasone/salmeterol or budesonide/formoterol was
used for our previous study in vitro [22]. In the present
study in vivo, CIC/IND was chosen because their drug
half-lives are longer than those used for the previous
study, which was adequate for our proposal that drug
efficacy should persist over a day in this protocol.
Although the poly I:C (3 μg i.t.)-induced upregulation of
PD-L1 was not affected by CIC or IND when used
independently, it was completely suppressed by treat-
ment with CIC plus IND (Fig. 3a). The administration of
poly I:C, 30 μg, markedly upregulated the expression of
PD-L1, which was not affected by CIC or IND alone.
The upregulation was significantly suppressed by CIC
plus IND (Fig. 3b).
Although the poly I:C (3 μg i.t.)-induced neutrophilia
was not affected by CIC or IND alone, it was signifi-
cantly suppressed by treatment with CIC plus IND
(Fig. 4a). The administration of poly I:C, 30 μg, induced
marked neutrophilia. The neutrophilia was not affected
by CIC or IND alone or CIC plus IND (Fig. 4b). Poly
Fig. 1 Poly I:C-induced upregulations of PD-L1 on BEAS-2B cells were suppressed by low-concentration of CIC plus IND, but not by either when
administered independently. Cells were pretreated with CIC (a), IND (b), and CIC + IND (c) for 2 h and administered with poly I:C (3 μg/ml) to the
culture medium for 24 h, and then processed for flow cytometric analysis of PD-L1. *p < 0.05 compared with stimulated control. Data is expressed
as the means ± SEM of 7–10 experiments
Fig. 2 Intratracheal instillation of poly I:C induced upregulation of PD-L1 in the lung cells and neutrophilic inflammation in mice. Mice were anesthetized
and received intratracheal instillation (i.t.) of poly I:C, 30 μg. At each time point, mice were sacrificed, bronchoalveolar lavage was performed, and then the
lungs were collected. The lung cell suspensions were stained with FITC-conjugated anti-keratin 5/8 mAb and biotinylated anti-mouse PD-L1 mAb, followed
by SAv-PE conjugate, and then processed for flow cytometry. The representative histograms of PD-L1 on keratin 5/8 mAb-positive cells in the lungs are
shown and assessed by the mean florescence intensity (MFI). a Differential cell counts for bronchoalveolar lavage fluid were performed
(b). *p < 0.05 compared with stimulated control. Data is expressed as the means ± SEM of 4–5 mice
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I:C, 30 μg, did not affect the number of alveolar macro-
phages in BALF but the number was significantly in-
creased by CIC, IND, and CIC plus IND, when used
both independently and as a combination. There was no
significant difference among those three groups.
The administration of poly I:C, 3 μg, increased the
concentration of KC in BALF compared to the sham-
treated control. Although the increase was not affected
by CIC or IND when used independently, it was signifi-
cantly suppressed by treatment with CIC plus IND
(Fig. 5a). The administration of poly I:C, 30 μg, also in-
creased the concentration of KC. The increase was not
significantly affected by independent uses of CIC, IND,
or CIC plus IND (Fig. 5b). The administration of poly
I:C, 3 and 30 μg, increased the concentrations of MIP-
1β and IL-6 in BALF compared to the sham-treated
controls. The increases were not significantly affected by
either CIC or IND or CIC plus IND.
Discussion
In the present study, combination effects of CIC/IND
were examined for the expression of PD-L1 and inflam-
mation in dsRNA-induced models of airway viral infec-
tion. We postulated that two doses of poly I:C could
reflect light and heavy infection mainly based on RSV-
infection in humans. It is well known that a proportion
of infants with RSV infection develop severe bronchio-
litis whereas a majority of RSV-infected infants and
Fig. 3 Poly I:C-induced upregulations of PD-L1 on lung cells were suppressed by CIC plus IND, but not by either when administered independently.
Mice were anesthetized and received intratracheal instillation (i.t.) of poly I:C, 3 μg (a) or 30 μg (b). Mice were sacrificed and the lungs were collected.
The lung cell suspensions were stained with FITC-conjugated anti-keratin 5/8 mAb and biotinylated anti-mouse PD-L1 mAb, followed by
SAv-PE conjugate, and then processed for flow cytometry. CIC (3 μg) and/or IND (3 μg) i.t. were administered 4 h before poly I:C stimulation. The drug
effects were evaluated 24 h after poly I:C stimulation, *p < 0.05 compared with stimulated control. Data is expressed as the means ± SEM of
13–24 mice
Fig. 4 Low-dose poly I:C-induced neutrophilic inflammation were suppressed by CIC plus IND, but not by either when administered independently.
Mice were anesthetized and received poly I:C, 3 μg (a) or 30 μg (b) i.t., 4 h after the administration of CIC (3 μg) and/or IND (3 μg) i.t.. 24 h after poly I:C
administration, bronchoalveolar lavage fluid was collected and differential cell counts were performed. *p < 0.05 compared with stimulated control.
Data is expressed as the means ± SEM of 10–20 mice
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healthy adults have limited disease such as cold-like
symptoms. Although the precise mechanisms explaining
those different patterns of outcomes remain uncertain,
several studies suggested that neutrophilic inflammation
may be readout of viral loads [26, 27]. A part of them
may be derived from net burden of viral dsRNA. There
have been several studies that used poly I:C in order to
mimic airway viral infection [28–30]. These studies
showed that a single topical administration of poly I:C to
the respiratory tracts dose-dependently induced neutro-
philic airway inflammation and increased KC, MIP-1β,
and IL-6 in BALF, which was also confirmed in the
present study. In the experiments of poly I:C (3 μg i.t.)
as a model of light infection, the upregulation of PD-L1,
neutrophilic inflammation and the elevation of KC were
significantly suppressed by CIC plus IND, but not by
CIC or IND alone. Given that KC is a strong chemo-
attractant for neutrophils, the reduction of neutrophilic
inflammation may be the outcome of reduced produc-
tion of KC by CIC plus IND. In the experiments of poly
I:C (30 μg) as a model of heavy infection, the upregula-
tion of PD-L1 was also suppressed by CIC plus IND but
the neutrophilic inflammation and the productions of
KC, MIP-1β, and IL-6 in BALF were not attenuated.
These results suggest that the suppression of PD-L1 by
CIC plus IND was not due to reduced impact of poly
I:C-induced neutrophilic inflammation. We did not
measure PD-1 because methodological limitation in this
study. The use of poly I:C, a synthetic double-stranded
RNA, may mimic virus-induced innate immune re-
sponses but not induce viral antigen-induced adoptive
immune responses including viral antigen-specific CTLs
expressing PD-1. We also did not measure PD-L2 be-
cause pathophysiological roles of PD-L2 in airway viral
infection remain uncertain.
The synergy of CIC/IND may be partly explained by
its direct effect on epithelial cells according to the re-
sults obtained from the study in vitro using cultured
BEAS-2B cells. In the study in vivo, the expression of
PD-L1 was assessed for keratin 5/8 mAb-positive cells
that include epithelial cells and myeloid-derived inflam-
matory cells. The myeloid-derived dendritic cells in-
crease their expression of PD-L1 in response to dsRNA
[17, 18, 31]. Recent investigations revealed that there are
different neutrophil subsets in mice and humans [32–34].
A CD16high/CD62Ldim subset is known to suppress
lymphocyte proliferation and induces lymphocyte apop-
tosis, through PD-L1 expression on this subset [33, 34].
These studies raise a possibility that suppression of PD-L1
expression in CIC/IND-treated mice may be partly due to
downregulation of PD-L1 on the neutrophil subset.
Although there has been no literature showing the ef-
fect of ICS plus LABA on virus-induced upregulation of
PD-L1 in vivo, a previous study showed that treatment
Fig. 5 Low-dose poly I:C-induced increases in KC in BALF were suppressed by CIC plus IND, but not by either when administered independently.
Effects of CIC and IND used independently and their combination on airway inflammation induced by poly I:C stimulation of mice. Mice were
anesthetized and received poly I:C, 3 μg (a) or 30 μg (b) i.t., 4 h after the administration of CIC (3 μg) and/or IND (3 μg) i.t.. Twenty four hours
after poly I:C administration, bronchoalveolar lavage fluid was collected and ELISA of KC, MIP-1β and IL-6 were performed. *p < 0.05 compared
with stimulated control. Data is expressed as the means ± SEM of 6–12 mice
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of RSV-infected mice with fluticasone propionate plus
salmeterol resulted in a 50% decrease of RSV titer in the
lung and a reduction in neutrophils compared to either
of drugs alone [35]. The decrease of viral titer by ICS
plus LABA may affect the expression status of PD-L1 in
real viral infection. The presented model has a technical
limitation. Viruses can amplify themselves within several
days of initial airway infection, whereas poly I:C can be
eliminated by the lung soon after administration, making
it difficult to elucidate sub-chronic immune responses to
viral infection.
It is important to consider the outcome of PD-L1 sup-
pression by ICS/LABA on airway viral infection. The
upregulation of PD-L1 on epithelial cells render virus-
specific CTLs to fail to eradicate virus-infected epithelial
cells [14, 15]. The upregulation of PD-L1 on myeloid-
derived inflammatory cells, particularly the neutrophil
subset described above, suppress lymphocyte proliferation,
induce lymphocyte apoptosis, and then compromise anti-
pathogen host defense [34, 36]. With this regard, ICS/
LABA treatment may be beneficial for earlier virus eradica-
tion. On the other hand, a recent study reported that
PD-L1 upregulation on a subset of dendritic cells pre-
vents excessive immune reaction triggered by RSV
[18]. Several studies provided novel information re-
garding the expression kinetics of PD-L1 in micro-
organism infections. One study showed that influenza
virus-induced expression of PD-L1 was decreased on
macrophages in subjects with COPD compared with
those in control subjects [37]. The other study
showed that early-life Chlamydia respiratory infection-
induced PD-L1 promoted severe inflammation during
inflammation, permanent reductions in lung function,
and the development of more severe allergic airway
disease in later life in a mouse model of lung inflam-
mation [38]. As for human rhinovirus, the most com-
mon virus linked to exacerbation of asthma and
COPD, human airway epithelial cells infected with the
virus upregulated the expression of PD-L1 [13]. These
studies suggest the diversity in the expression kinetics
of PD-L1 and then the impacts of infection-induced
upregulation of PD-L1 may be different among under-
lying diseases. Further investigation is required to dis-
criminate PD-L1-expressing cell types in the lungs
and to evaluate ICS/LABA on PD-L1 expression on
each cell type.
Conclusions
Administration of poly I:C upregulated the expression of
PD-L1, induced neutrophilia and increased KC, MIP-1β
and IL-6 in BALF. The upregulation of PD-L1, neutro-
philic inflammation and increase of KC were suppressed
by ciclesonide plus indacaterol, but not by either when
used independently of each other.
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